RxDoctor Payments Data

Kathy Summers

Obstetrics · Houston, TXNPI 1972505808

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations.

$1,293in general payments, 2019–2025

Across 71 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myovant Sciences Inc.$191
  • AbbVie$146
  • Sumitomo Pharma America, Inc.$129
  • Pfizer$119
  • Astellas Pharma US Inc$111
  • Organon$85
  • plus $512 from 17 others

What the payments were for

  • Food & beverage$1,293100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,293 in reported general payments places this provider in the 55th percentile of 85 obstetrics providers in Texas.

See all obstetrics providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol15$1,466

Paid to pharmacies, not to this prescriber.

Other obstetrics in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →